ADRIENNE JOHNSON: Open Payments
NPI 1235575788 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 15 payments from 7 companies in 2025. Trend: 2023 $192 · 2024 $57 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 7 | $153 |
| Novo Nordisk Inc | 1 | $94 |
| ABBVIE INC. | 2 | $43 |
| Dexcom, Inc. | 1 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Ardelyx, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: QUTENZA, Ozempic, Dexcom G6 Transmitter, XIFAXAN, IBSRELA, VRAYLAR, UBRELVY, CAPLYTA.
Industry payments across AK — which companies pay providers there.
